LifeSci Capital Downgrades Sionna Therapeutics (SION) to Market Perform
Tweet
Share
E-mailGet Alerts SION Hot Sheet
Price: $6.03 +2.73%
Rating Summary:
1 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Rating Summary:
1 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 36
Join SI Premium – FREE
LifeSci Capital analyst Gaurav Maini downgraded Sionna Therapeutics (NASDAQ: SION) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Sionna Therapeutics click here. For more ratings news on Sionna Therapeutics click here.
Shares of Sionna Therapeutics closed at $51.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- StrategX extends private placement deadline to September 30
- Altrova Health Reports Third Quarter Fiscal 2026 Financial Results
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
